48 related articles for article (PubMed ID: 24814755)
1. Bortezomib for antibody-mediated rejection of kidney transplant in youth: Associations with donor-specific antibody.
Fulchiero R; Galea L; Hewlett J; Savant JD; Lopez S; Amaral S; Viteri B
Pediatr Transplant; 2024 Aug; 28(5):e14774. PubMed ID: 38808699
[TBL] [Abstract][Full Text] [Related]
2. Acute rejection post lung transplant.
Hanks J; Girard C; Sehgal S
Curr Opin Pulm Med; 2024 Jul; 30(4):391-397. PubMed ID: 38656281
[TBL] [Abstract][Full Text] [Related]
3. Any Progress in the Treatment of Antibody-Mediated Rejection?
Budde K; Dürr M
J Am Soc Nephrol; 2018 Feb; 29(2):350-352. PubMed ID: 29371423
[No Abstract] [Full Text] [Related]
4. Bortezomib-Induced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case.
Balwani M; Pasari A; Gurjar P; Sejpal K; Bawankule C; Tolani P; Dubey S; Kashiv P; Bhawane A; Malde S; Gupta S
Cureus; 2024 Apr; 16(4):e58743. PubMed ID: 38779283
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib use in a pediatric cardiac transplant center.
Zinn MD; L'Ecuyer TJ; Fagoaga OR; Aggarwal S
Pediatr Transplant; 2014 Aug; 18(5):469-76. PubMed ID: 24931171
[TBL] [Abstract][Full Text] [Related]
6. Use of bortezomib as anti-humoral therapy in kidney transplantation.
Yang KS; Jeon H; Park Y; Jo IH; Kim JI; Moon IS; Choi BS; Park CW; Yang CW; Kim YS; Chung BH
J Korean Med Sci; 2014 May; 29(5):648-51. PubMed ID: 24851019
[TBL] [Abstract][Full Text] [Related]
7. Treatment of antibody-mediated rejection in renal transplant patients: a clinical practice survey.
Burton SA; Amir N; Asbury A; Lange A; Hardinger KL
Clin Transplant; 2015 Feb; 29(2):118-23. PubMed ID: 25430052
[TBL] [Abstract][Full Text] [Related]
8. Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies.
Pan H; Gazarian A; Dubernard JM; Belot A; Michallet MC; Michallet M
Front Immunol; 2016; 7():116. PubMed ID: 27092138
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.
Pearl MH; Nayak AB; Ettenger RB; Puliyanda D; Palma Diaz MF; Zhang Q; Reed EF; Tsai EW
Pediatr Nephrol; 2016 Aug; 31(8):1341-8. PubMed ID: 27048228
[TBL] [Abstract][Full Text] [Related]
10. Management of sensitized pediatric patients prior to renal transplantation.
Pirojsakul K; Desai D; Lacelle C; Seikaly MG
Pediatr Nephrol; 2016 Oct; 31(10):1691-8. PubMed ID: 26801944
[TBL] [Abstract][Full Text] [Related]
11. Antibody-mediated rejection in pediatric kidney transplantation: pathophysiology, diagnosis, and management.
Ng YW; Singh M; Sarwal MM
Drugs; 2015 Apr; 75(5):455-72. PubMed ID: 25813498
[TBL] [Abstract][Full Text] [Related]
12. Challenges in pediatric renal transplantation.
Peruzzi L; Amore A; Coppo R
World J Transplant; 2014 Dec; 4(4):222-8. PubMed ID: 25540732
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen.
Nguyen S; Gallay B; Butani L
Pediatr Transplant; 2014 Aug; 18(5):463-8. PubMed ID: 24814755
[TBL] [Abstract][Full Text] [Related]
14. Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection.
Walsh RC; Everly JJ; Brailey P; Rike AH; Arend LJ; Mogilishetty G; Govil A; Roy-Chaudhury P; Alloway RR; Woodle ES
Transplantation; 2010 Feb; 89(3):277-84. PubMed ID: 20145517
[TBL] [Abstract][Full Text] [Related]
15. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
[TBL] [Abstract][Full Text] [Related]
16. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
Hardinger KL; Murillo D
Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
Sureshkumar KK; Hussain SM; Marcus RJ; Ko TY; Khan AS; Tom K; Vivas CA; Parris G; Jasnosz KM; Thai NL
Clin Nephrol; 2012 Mar; 77(3):246-53. PubMed ID: 22377258
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.
Fehr T; Gaspert A
Transpl Int; 2012 Jun; 25(6):623-32. PubMed ID: 22394269
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
